3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
127
Colonic Neoplasms
54
Rectal Neoplasms
49
Carcinoma, Hepatocellular
29
Stomach Neoplasms
22
Neoplasm Metastasis
22
Neoplasms
11
Pancreatic Neoplasms
9
Cholangiocarcinoma
8
Adenocarcinoma Of Esophagus
8
Esophageal Neoplasms
7
Liver Neoplasms
6
Biliary Tract Neoplasms
5
Recurrence
4
Ovarian Neoplasms
4
Gastrointestinal Neoplasms
4
Esophageal Squamous Cell Carcinoma
3
Digestive System Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Adenocarcinoma
3
Unresectable Metastatic Colorectal Cancer
2
Peritoneal Neoplasms
2
Neoplastic Cells, Circulating
2
Intestinal Neoplasms
2
Gastrointestinal Diseases
2
Gallbladder Neoplasms
2
Colorectal Cancer Metastatic
2
Cirrhosis, Familial, with Pulmonary Hypertension
2
Squamous Cell Carcinoma of Head and Neck
1
Interventions
Microscopy, Confocal
2
Indocyanine Green
2
Everolimus
2
varlilumab
1
Ultrasonography
1
Sunitinib
1
Simvastatin
1
Radiosurgery
1
Palliative Care
1
Neoadjuvant Therapy
1
Narrow Band Imaging
1
Interferon alpha-2
1
IFL protocol
1
Gastrectomy
1
Folfox protocol
1
Endoscopic Mucosal Resection
1
Drug Delivery Systems
1
Drug Combinations
1
Dermoscopy
1
Chemoradiotherapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Margins of Excision
×
Folfox protocol
×
Clear all
NCT04389086
2022-09-06
PelvEx II
Catharina Ziekenhuis Eindhoven
Phase 3
Recruiting
364 enrolled